Auvelity May Change How You Think About Depression: NMDA, Sigma-1, Dopamine & Clinical Pearls episode artwork

EPISODE · May 28, 2026 · 23 MIN

Auvelity May Change How You Think About Depression: NMDA, Sigma-1, Dopamine & Clinical Pearls

from Pearls and Prep

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY!Join our clinical library today on PATREON!👉 https://www.patreon.com/PearlsandPrepWe're diving into the nitty-gritty of a super cool antidepressant called Auvelity today. This bad boy is one of the first fresh faces in the antidepressant world in over 30 years, and it’s not just your run-of-the-mill serotonin booster. We're talking NMDA antagonism and sigma 1 receptor agonism—yeah, that’s some fancy science! We'll chat about a case study featuring Sarah, a marketing manager who's had it up to here with the usual meds that leave her feeling like a zombie. So, grab your headphones and let's unpack how Auvelity could be a game changer for folks who need a quicker fix without the cringe side effects. It’s all about finding that sweet spot where patients can actually feel better and get back to living their lives!32Auvelity May Change How You Think About Depression: NMDA, Sigma-1, Dopamine & Clinical PearlsPearls and [email protected]://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLinkTakeaways:Auvelity is a brand-new antidepressant that works differently from traditional meds, which is super cool.Patients often want immediate relief, and Auvelity can kick in faster than your average SSRI.The way Auvelity combines dextromethorphan and Wellbutrin is a game changer in treating depression.Understanding how a medication works is crucial for clinicians to explain it clearly to patients.This podcast really highlights the real-world challenges of prescribing meds in a busy practice setting.Not all antidepressants are one-size-fits-all, and we need to be flexible with treatment options for patients.Companies mentioned in this episode:ZoloftRemeronEffexorCymbaltaWellbutrinAuvelityEsketamineTMSLuvoxPaxilProzacThis podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

Episode metadata supplied by the publisher feed · Published May 28, 2026

Embed this episode

NOW PLAYING

Auvelity May Change How You Think About Depression: NMDA, Sigma-1, Dopamine & Clinical Pearls

0:00 23:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Pearls and Prep?

This episode is 23 minutes long.

When was this Pearls and Prep episode published?

This episode was published on May 28, 2026.

Can I download this Pearls and Prep episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!